Zentalis Pharmaceuticals

Zentalis lays off 40% to fund registrational trial of WEE1 drug

The FDA’s move to lift the hold on Zentalis’ clinical-stage drug may have been good news for the biotech—but it’s been bad news for some of its staff.

James Waldron Jan 29, 2025 4:42am

photo of a paraglider in the foreground with the alps in the background

Flagship-backed biotechs name new leaders—Chutes & Ladders

Nov 15, 2024 8:30am

FDA places hold on Zentalis’ WEE1 drug after two sepsis deaths

Jun 18, 2024 8:21am

FDA's Peter Marks doesn't plan to retire soon—Chutes & Ladders

Aug 4, 2023 9:30am

countdown 1 2 3 numbers count to three three

ASCO: Zentalis ovarian cancer data will take WEE1 to phase 3

May 26, 2023 8:40am

a number of parachutes leaving an airplane

Moderna promotes Andres to new strategy role—Chutes & Ladders

Sep 30, 2022 9:30am